- Saturday, April 1, 2023
7:45 AM – 8:00 AM CT
Welcome
7:45 AM – 8:00 AM CT
WelcomeCo-Chair: – Vanderbilt-Ingram Cancer Center
Co-Chair: – University of Chicago
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Co-Chair###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Co-Chair: – Vanderbilt-Ingram Cancer Center
### @@@ Sonia Kupfer, MD (she/her/hers) – University of Chicago ### 1849665###Co-Chair###Associate Professor of Medicine###University of Chicago###Co-Chair: – University of Chicago
### she/her/hers8:00 AM – 8:15 AM CT
15 - Session 15: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Yes
8:00 AM – 8:15 AM CT
Session 15: Debate: Is There a Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - YesPresenter: – Northwell Health Cancer Institute
Joseph Herman, MD, MSc, MHCM (he/him/his) – Northwell Health Cancer Institute ### 1849663###Presenter###Director of Clinical Research###Northwell Health Cancer Institute###Presenter: – Northwell Health Cancer Institute
### he/him/his8:15 AM – 8:30 AM CT
15 - Session 15: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - No
8:15 AM – 8:30 AM CT
Session 15: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - NoPresenter: – Columbia University Irving Medical Center
Lisa Kachnic, MD (she/her/hers) – Columbia University Irving Medical Center ### 1849664###Presenter###Professor and Chair, Department of Radiation Oncology###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### she/her/hers8:30 AM – 8:45 AM CT
15 - Session 15: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - Discussion
8:30 AM – 8:45 AM CT
Session 15: Debate: Is There A Role for Radiation Therapy in Borderline-Resectable Pancreatic Cancer? Yes vs No - DiscussionSession Moderator: – Vanderbilt-Ingram Cancer Center
Session Moderator: – University of Chicago
Panelist: – Northwell Health Cancer Institute
Panelist: – Columbia University Irving Medical Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Session Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Session Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Sonia Kupfer, MD (she/her/hers) – University of Chicago ### 1849665###Session Moderator###Associate Professor of Medicine###University of Chicago###Session Moderator: – University of Chicago
### she/her/hers @@@ Joseph Herman, MD, MSc, MHCM (he/him/his) – Northwell Health Cancer Institute ### 1849663###Panelist###Director of Clinical Research###Northwell Health Cancer Institute###Panelist: – Northwell Health Cancer Institute
### he/him/his @@@ Lisa Kachnic, MD (she/her/hers) – Columbia University Irving Medical Center ### 1849664###Panelist###Professor and Chair, Department of Radiation Oncology###Columbia University Irving Medical Center###Panelist: – Columbia University Irving Medical Center
### she/her/hers8:45 AM – 9:30 AM CT
16 - Session 16: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment Strategies
8:45 AM – 9:30 AM CT
Session 16: Improving the Management of Cholangiocarcinoma: Adopting Recent NCCN Guidelines to Improve Patient Care in Diagnosis, Molecular Testing, and Targeted Treatment StrategiesPresenter: – MD Anderson Cancer Center, The University of Texas
Milind M. Javle, MD – MD Anderson Cancer Center, The University of Texas ### 944699###Presenter###Professor of Medicine###MD Anderson Cancer Center, The University of Texas###Presenter: – MD Anderson Cancer Center, The University of Texas
### 9:30 AM – 10:30 AM CT
An Exelixis Product for the Clinical Management of HCC. Speaker: Amit Mahipal, MBBS, MPH
9:30 AM – 10:30 AM CT
Non-CME Innovation Theater (Sponsored by Exelixis)
10:30 AM – 10:45 AM CT
Exhibit Hall
10:30 AM – 10:45 AM CT
Exhibit Hall
10:45 AM – 11:30 AM CT
Session 17: Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma
10:45 AM – 11:30 AM CT
Session 17: Evaluating Current and Emerging Targeted Therapies in Hepatocellular CarcinomaPresenter: – Memorial Sloan Kettering Cancer Center
Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center ### 697827###Presenter###Professor###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 11:30 AM – 12:00 PM CT
Exhibit Hall
11:30 AM – 12:00 PM CT
Exhibit Hall
12:00 PM – 12:45 PM CT
23 - Session 18: Significance of Cancer Genetics
12:00 PM – 12:45 PM CT
Session 18: Significance of Cancer GeneticsPresenter: – University of Chicago
Sonia Kupfer, MD (she/her/hers) – University of Chicago ### 1849665###Presenter###Associate Professor of Medicine###University of Chicago###Presenter: – University of Chicago
### she/her/hers12:45 PM – 1:30 PM CT
21 - Session 19: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and Gastric
12:45 PM – 1:30 PM CT
Session 19: Rising Incidence of Early-Onset GI Malignancies: Pancreatic, CRC, and GastricPresenter: – Vanderbilt-Ingram Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Presenter###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Presenter: – Vanderbilt-Ingram Cancer Center
###
